Soligenix Announces Publication of Positive Pre-cl
Post# of 76
- Rapid Immune Responses Demonstrated with CoVaccine HT™ Adjuvant in a Prototype Vaccine
- Key Attributes including Generation of Neutralizing Antibodies, Th1 Antibody and Cell Mediated Responses Established
http://ir.soligenix.com/2020-07-28-Soligenix-...19-Vaccine